Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections.
Saved in:
| Title: | Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections. |
|---|---|
| Authors: | Orenstein, Robert1 (AUTHOR), Hecht, Gail2 (AUTHOR), Harvey, Adam3 (AUTHOR), Tillotson, Glenn4 (AUTHOR), Khanna, Sahil5 (AUTHOR) khanna.sahil@mayo.edu |
| Source: | Open Forum Infectious Diseases. Sep2023, Vol. 10 Issue 9, p1-6. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
